U.S. Lawmakers Urge HHS, FDA To Update Off-Label Communication Policy

Two United States House of Representatives committee chairmen recently wrote a strongly worded letter to Health and Human Services (HHS) Secretary Sylvia Mathews Burwell, urging her to let the U.S. Food and Drug Administration (FDA) clarify its position on drug and device off-label use, and to inform Congress about its current thinking on the matter.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news